Genomtec S.A. has launched an initial public offering of up to 730,000 J-series shares. The maximum price per share was agreed at PLN 11. The Company plans to raise funding of approx. 8 million PLN. After shares registration, they will represent 8.9% of the overall Company\u2019s share capital. The funding will secure industrialization process and also global commercialization of the Genomtec ID platform. Company\u2019s goal is to debut on the NewConnect Stock Exchange market at GPW in Q1 2021.<\/p>\n
Shares issue process will proceed in a form of an initial public offering, based on the information enclosed in the Memorandum. The book-building process is planned for period of 14th<\/sup> to 22nd<\/sup> October, whereas the public official announcement of the price per issued share is estimated on 23rd<\/sup>. Shares\u2019 subscription process shall be opened from 23rd<\/sup> October Genomtec S.A. has launched an initial public offering of up to 730,000 J-series shares. The maximum price per share was agreed at PLN 11. The Company plans to raise funding of approx. 8 million PLN. After shares registration, they will represent 8.9% of the overall Company\u2019s share capital. The funding will secure industrialization process and […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-32511","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\n
to 4th<\/sup> November. The shares\u2019 allocation stage is scheduled for 5th<\/sup> November, 2020.<\/p>\n","protected":false},"excerpt":{"rendered":"